Cargando…
Clinical Implications of Acquired BRAF Inhibitors Resistance in Melanoma
Understanding the role of mitogen-activated protein kinase (MAPK) pathway-activating mutations in the development and progression of melanoma and their possible use as therapeutic targets has substantially changed the management of this neoplasm, which, until a few years ago, was burdened by severe...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766699/ https://www.ncbi.nlm.nih.gov/pubmed/33419275 http://dx.doi.org/10.3390/ijms21249730 |